Novel Single-Cell Biomarker Strategies for Autoimmune Disease and Adverse Events in Immunotherapy
Discover biomarkers that could elucidate the mechanism of various autoimmune disorders as well as autoimmune and inflammatory reactions to immunotherapies
![[wpbb post:title]](https://isoplexis.com/wp-content/uploads/2019/07/Webinar-Website-Covers-4.30_Artboard-8.png)
Dr. Rong Fan, Yale University
- Explore IsoPlexis’ advanced immune-based approaches in systemic lupus erythematosus and adverse events like cytokine release syndrome and neurotoxicity in cell therapy
- Determine correlates and drivers of adverse reactions using single-cell functional proteomics
- Learn how these biomarkers may improve therapeutic development and intervention
